Revenue (TTM) Chart

Historical Revenue (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2026 2.255B
June 30, 2026 2.255B
March 31, 2026 2.127B
December 31, 2025 1.993B
September 30, 2025 1.866B
June 30, 2025 2.063B
March 31, 2025 2.370B
December 31, 2024 2.694B
September 30, 2024 3.026B
June 30, 2024 3.008B
March 31, 2024 3.001B
December 31, 2023 2.974B
September 30, 2023 2.959B
June 30, 2023 2.899B
March 31, 2023 2.860B
December 31, 2022 2.791B
September 30, 2022 2.795B
June 30, 2022 2.808B
March 31, 2022 2.817B
December 31, 2021 2.810B
September 30, 2021 2.759B
June 30, 2021 2.687B
March 31, 2021 2.540B
December 31, 2020 2.537B
September 30, 2020 2.507B
Date Value
June 30, 2020 2.527B
March 31, 2020 2.612B
December 31, 2019 2.595B
September 30, 2019 2.556B
June 30, 2019 2.517B
March 31, 2019 2.475B
December 31, 2018 2.448B
September 30, 2018 2.402B
June 30, 2018 2.327B
March 31, 2018 2.246B
December 31, 2017 2.146B
September 30, 2017 2.065B
June 30, 2017 1.986B
March 31, 2017 1.931B
December 31, 2016 1.868B
September 30, 2016 1.839B
June 30, 2016 1.823B
March 31, 2016 1.798B
December 31, 2015 1.800B
September 30, 2015 1.791B
June 30, 2015 1.805B
March 31, 2015 1.821B
December 31, 2014 1.830B
September 30, 2014 1.805B
June 30, 2014 1.762B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks
Start Trial
Globus Medical, Inc. 3.140B
Veracyte, Inc. 581.78M
IDEXX Laboratories, Inc. 4.662B
Penumbra, Inc. 1.560B
Abbott Laboratories 48.23B